Sharp Fluidics® Announces a Clinical Study of its Engineered Sharps Injury Prevention Device, Operative Armour®
News provided by
Share this article
Share this article
SAN FRANCISCO, Dec. 22, 2020 /PRNewswire/ The first prospective, case-controlled clinical study of an Engineered Sharps Injury Prevention (ESIP) device to prevent Needle Stick Injuries (NSI) in an operating room demonstrated that the use of Operative Armour®, a wearable needle safety and workflow efficiency device, reduces surgical needle passes and handling during surgical closure. This study, Efficacy of a Novel Intraoperative Engineered Sharps Injury Prevention Device: Pilot Usability and Efficacy Trial, Jenny Hillary, M.D., et al. conducted at The Johns Hopkins University School of Medicine, was published in JMIR Perioperative Medicine.